Initial supplementary dose of dolutegravir in second-line antiretroviral therapy: a noncomparative, double-blind, randomized placebo-controlled trial

<p><strong>Background:</strong> Dolutegravir concentrations are reduced by efavirenz induction effect necessitating twice-daily dolutegravir dosing when coadministered. Efavirenz induction persists for several weeks after stopping, which could potentially select for dolutegravir re...

Mô tả đầy đủ

Chi tiết về thư mục
Những tác giả chính: Zhao, Y, Griesel, R, Omar, Z, Simmons, B, Hill, A, van Zyl, G, Keene, C, Maartens, G, Meintjes, G
Định dạng: Journal article
Ngôn ngữ:English
Được phát hành: Oxford University Press 2023

Những quyển sách tương tự